ライフサイエンスコーパス: dried blood spot

1 0x, was occasionally observed with FFPET and dried blood spot.

2 h concentrations of tenofovir diphosphate in dried blood spots.

3 d by tenofovir diphosphate concentrations in dried blood spots.

4 tively correlated with CMV viral load in the dried blood spots.

5 genomic DNA obtained from Guthrie cards with dried blood spots.

6 , amitriptyline, lidocaine, and sunitinib in dried blood spots.

7 agnosis of HIV infection in infants by using dried blood spots.

8 ar dystrophy by the creatine kinase level on dried blood spots.

9 R method to detect HIV type 1 (HIV-1) DNA in dried blood spots.

10 o the measurement of transferrin receptor in dried blood spots.

11 oxoplasma-specific immunoglobulin M (IgM) in dried blood spots.

12 he authors measured EDA in serum, saliva and dried blood spots.

13 he microscope) and another one consisting of dried blood spots.

14 100 person-years if drug was not detected in dried blood spots, 2.3 infections per 100 person-years i

15 1 pg/mL (3.47 pmol/L), total testosterone in dried blood spots (8-10 muL) with a LLOQ of 40 pg/mL, an

16 ospital in Kampala, Uganda, and obtained for dried blood spot analysis.

17 storage at room temperature, the punched out dried blood spot and the foam was dissolved in 300 muL o

18 noassay (ELISA) for quantifying insulin from dried blood spots and demonstrate its application in a l

19 ds itself to samples such as tumor biopsies, dried blood spots and fluids including urine and CSF to

20 of samples enriched for proviral DNA such as dried blood spots and increased use of next-generation s

21 ment with activity data determined from both dried blood spots and serum samples, giving an informati

22 the recent improvements for accurately using dried blood spots and the imminent appearance to the mar

23 ssess inflammatory marker levels in neonatal dried blood spots and their association with later risk

24 say (ELISA) for quantifying adiponectin from dried blood spots and then demonstrate its application i

25 n or sonication) of the paper containing the dried blood spots, and acidification of extraction solve

26 measured levels of tenofovir diphosphate in dried blood spots; and (3) examine patterns of risk beha

27 Cotinine levels in dried blood spots are an accurate biomarker of maternal

28 The archived dried blood spots are an important and precious resource

29 Drug concentrations in dried blood spots are strongly correlated with protectiv

30 n umbilical cord blood to assess cotinine in dried blood spots as a biomarker of maternal smoking clo

31 hown by their performance in reactions using dried blood spots as the enzyme source.

32 milk protein) were analyzed in eluates from dried blood spots by enzyme-linked immunosorbent assay.

33 of Hb variants by direct surface sampling of dried blood spots by use of an Advion Triversa Nanomate

34 Dried blood spots can be used for comprehensive, untarge

35 f serum ferritin and transferrin receptor in dried blood spots can be used to facilitate the identifi

36 s determined by polymerase chain reaction on dried blood spots collected at 6 and 12 weeks of age.

37 extracts from human whole blood samples and dried blood spots collected on chromatography paper.

38 A fixed area punch in dried blood spot (DBS) analysis is assumed to contain a

39 Comparison of Aptima results for paired dried blood spot (DBS) and plasma specimens archived fro

40 s of this study were to develop and validate dried blood spot (DBS) assays for the quantification of

41 Since March 2004, we obtained 2135 dried blood spot (DBS) citrulline samples from 57 intest

42 A dried blood spot (DBS) is a well-accepted means for the

43 oof-of-concept study combining water-soluble dried blood spot (DBS) material in liquid chromatography

44 The dried blood spot (DBS) matrix has significant utility fo

45 Monitoring by dried blood spot (DBS) provides patients the opportunity

46 ated with the bioanalytical methods used for dried blood spot (DBS) sample analysis.

47 ogeneity issues associated with conventional dried blood spot (DBS) sample when a subpunch is taken.

48 [25(OH)D3] concentrations in stored neonatal dried blood spot (DBS) samples are associated with pedia

49 To improve EID services in Ukraine, dried blood spot (DBS) samples obtained from 237 HIV-exp

50 Dried blood spot (DBS) samples on filter paper are surgi

51 irect quantitative bioanalysis of drugs from dried blood spot (DBS) samples, using an MS detector, wi

52 oglobulin can be measured in either serum or dried blood spot (DBS) samples.

53 e useful for online cleanup of extracts from dried blood spot (DBS) samples.

54 here is an increasing interest in the use of dried blood spot (DBS) sampling and multiple reaction mo

55 The potential of dried blood spot (DBS) sampling as an alternative for cl

56 Dried blood spot (DBS) sampling is recognized as a valua

57 We instituted dried blood spot (DBS) specimen monitoring of citrulline

58 Blood samples were collected as dried blood spot (DBS) specimens from all participants f

59 d has gained substantial experience with the dried blood spot (DBS) technique as an alternative.

60 The dried blood spot (DBS) technique can be used to collect,

61 costs, and simplified shipping and storage, dried blood spot (DBS) techniques have faced adoption re

62 Dried blood spot (DBS) technology is believed to be a vi

63 Dried blood spot (DBS), dried plasma spot (DPS), and pla

64 se of umbilical cord (UC) tissue and newborn dried blood spot (DBS)-extracted genomic DNA (gDNA) as a

65 Dried blood spots (DBS) are an alternative specimen type

66 Since dried blood spots (DBS) are routinely collected for meta

67 Dried blood spots (DBS) are simpler to prepare, store, a

68 Drug concentrations in hair and dried blood spots (DBS) are used to assess long-term-exp

69 Dried blood spots (DBS) are useful for molecular assays

70 tly hinder the development and acceptance of dried blood spots (DBS) as a widely used quantitative bi

71 etroviral therapy (ART) guidelines recommend dried blood spots (DBS) as an alternative specimen type

72 the MAS assay to determine subtype B DRMs in dried blood spots (DBS) collected from patients on antir

73 Dried blood spots (DBS) collected onto filter paper have

74 The use of dried blood spots (DBS) could ameliorate many problems o

75 lovirus (CMV) load in finger-stick-collected dried blood spots (DBS) could potentially be useful for

76 ranulocytes isolated by magnetic sorting and dried blood spots (DBS) derived from 50 mul of periphera

77 and robust LC-MS/MS-based enzyme assay using dried blood spots (DBS) for the diagnosis of pyridox(am)

78 system for online extraction and analysis of dried blood spots (DBS) from DBS paper cards to a multid

79 We tested 617 dried blood spots (DBS) from human immunodeficiency viru

80 Dried blood spots (DBS) have been used as alternative sp

81 ucting HIV Early Infant Diagnosis (EID) from dried blood spots (DBS) in low- to middle-income countri

82 ed a method for analyzing perchlorate in the dried blood spots (DBS) of newborns.

83 rug concentrations in clinical studies using dried blood spots (DBS) on paper, rather than convention

84 e, we examined the stability of HIV-1 DNA in dried blood spots (DBS) stored in humid heat and at -20

85 etection (LOD) of the new test in plasma and dried blood spots (DBS) was determined with the 2nd Inte

86 In total, dried blood spots (DBS) were collected from 276 individu

87 HIV genotyping from dried blood spots (DBS) with noncommercial (in-house) as

88 s for inborn errors of metabolism (IEM) from dried blood spots (DBS) with quality assurance.

89 he serum samples and 40-10,000 pg/mL for the dried blood spots (DBS) with R(2) >0.998.

90 fingerstick placed on filter paper (known as dried blood spots (DBS)) is more advantageous.

91 measure IFX in 100-fold diluted extracts of dried blood spots (DBS), and LOD achieved was below 2 ng

92 frica for early infant diagnosis of HIV from dried blood spots (DBS), viral load monitoring with this

93 improve the analysis of therapeutic drugs in dried blood spots (DBS).

94 ity and yield of DNA extracted from neonatal dried blood spots (DBS).

95 bias would facilitate more widespread use of dried blood spots (DBS).

96 ermination of methotrexate polyglutamates in dried blood spots (DBS).

97 (n = 20), cerebrospinal fluid (CSF; n = 36), dried blood spots (DBS; n = 104), and dried plasma spots

98 ve developed and applied a broadly sensitive dried-blood-spot (DBS)-based genotyping assay for survei

99 nalysis of targeted drugs and metabolites in dried blood spots (DBSs) and whole mouse thin tissue sec

100 em mass spectrometry (tandem-MS) analysis of dried blood spots (DBSs) collected at birth can identify

101 try can identify metabolite abnormalities in dried blood spots (DBSs) from affected patients, with th

102 an observational cohort study using data and dried blood spots (DBSs) from the Breastfeeding, Antiret

103 Dried blood spots (DBSs) have had a long history in dise

104 easible in resource-limited settings, use of dried blood spots (DBSs) is being adopted.

105 Ten dried blood spots (DBSs) were assembled that contained P

106 Dried blood spots (DBSs), collected for the newborn scre

107 Whole genome amplification of dried blood spot DNA has been used to provide DNA for ge

108 DNA is more robust than genotyping amplified dried blood spot DNA, is comparable in cost, and can be

109 require robust, high-accuracy genotyping of dried blood spot DNA.

110 ol to erythronate in stable isotope-assisted dried blood spot experiments.

111 ure requires a simple extraction step from a dried blood spot followed by the quantification of produ

112 analysis used genomic DNA extracted from the dried blood spot followed by whole genome amplification

113 screening by creatine kinase (CK) levels in dried blood spots followed by mutation detection in thos

114 However, homogenization of the dried blood spots, followed by a 24 h exposure to solven

115 provinces provided anonymous survey data and dried blood spots for HIV serostatus assessment.

116 experiences, and 1,220 (70.2%) also provided dried blood spots for HIV testing.

117 (MS/MS) based assays of lysosomal enzymes in dried blood spots for the early detection of Pompe, Fabr

118 rams used elevated creatine kinase levels in dried blood spots for the initial screening, with the di

119 blood for the Determine and Vikia tests and dried blood spots for the reference standard test (AxSYM

120 ) were tested for malarial parasitemia using dried blood spots from 12, 24, and 36 weeks of age.

121 a Genetic Disease Screening Program provided dried blood spots from 428 newborns delivered in 2001-20

122 was then compared with microscopy using 891 dried blood spots from a cohort of 77 Ugandan children f

123 e (PPT1) and tripeptidyl peptidase (TPP1) in dried blood spots from newborns using tandem mass spectr

124 d by measuring immunoreactive trypsinogen on dried blood spots (from April 1985 through June 1991) or

125 complexity are high, DNA was extracted from dried blood spots, genes of interest were amplified, amp

126 d, we found that measurements of cotinine in dried blood spots had high sensitivity (92.3%) and speci

127 The use of dried blood spots has increased in research and clinical

128 hensive acyl-specific lipidomic profiling of dried blood spots has yet to be examined.

129 ction and transportation of samples, such as dried blood spots, has improved test accessibility, the

130 ration sequencing of FFPET, whole blood, and dried blood spot in the evaluation of inherited CV disor

131 essfully quantified fasting adiponectin from dried blood spots in 13,329 of 13,879 (96%) children.

132 Paediatricians collected dried blood spots in a follow-up of 13,879 fasted childr

133 Creatine kinase (CK) levels are increased on dried blood spots in newborns related to the birthing pr

134 red glucocerebrosidase enzymatic activity in dried blood spots in patients with Parkinson's disease (

135 e measured drug concentrations in plasma and dried blood spots in seroconverters and a random sample

136 erval, 19%-47%) by increasing DNA input from dried blood spots into polymerase chain reaction.

137 genetic material, including cheek swabs and dried blood spots, is described briefly.

138 ted blood specimens from newborns, stored as dried blood spots, may provide a low-cost method to obje

139 crolimus levels were assessed by a validated dried blood spot method for sampling and measurement.

140 llected by the patients themselves using the dried blood spot method.

141 llected by the patients themselves using the dried blood spot method.

142 specimen type (FFPET versus whole blood and dried blood spot; n=12).

143 T-cell receptor excision circles (TRECs) in dried blood spots obtained at birth permits population-b

144 The authors analyzed archival dried blood spots obtained from newborns to assess wheth

145 pproximately 3 microL of blood) punched from dried blood spots obtained from: i) whole blood standard

146 ss FMR1 methylation in DNA isolated from the dried blood spots of 36,124 deidentified newborn males.

147 markers of T and B cell numbers in neonatal dried blood spots of 99 children with cCMV and 54 childr

148 hods have been developed for the analysis in dried blood spots of steroids and lysosomal enzymes.

149 egy for detection of malaria parasites using dried blood spots offers a sensitive and efficient appro

150 uantitative analysis of enzyme activities in dried blood spots on newborn screening cards has emerged

151 We used dried blood spots once every 6 months provided by partic

152 lied its own cutoff of interpret results for dried blood spots prepared from either adults with serol

153 tyrosine, phenylalanine, and methionine on a dried blood spot requiring a 2 min run.

154 We obtained punch samples from dried blood spots routinely collected from HIV-exposed i

155 g viral load in many countries is to collect dried blood spot samples for testing in regional laborat

156 Dried blood spot samples from mothers and their offsprin

157 Using dried blood spot samples from patients with suspected ma

158 DNA was extracted from the neonatal dried blood spot samples obtained from the Danish Neonat

159 ive untargeted profiles can be obtained from dried blood spot samples that are comparable with whole

160 Dried blood spot samples were collected from HIV-exposed

161 tween April 5, 2007, and Oct 1, 2014, 16 046 dried blood spot samples were sent from 8859 children in

162 via liquid extraction surface analysis from dried blood spot samples, where hemoglobin is highly abu

163 iously been reported for tissue sections and dried blood spot samples.

164 newborns using 30,547 deidentified anonymous dried blood spot samples.

165 is introduced to address the limitations of dried blood spot sampling.

166 tions will facilitate the quality control of dried blood spot sequencing.

167 cability of our method for drug screening on dried blood spots showing excellent linearity (R(2) of 0

168 drolysis of IdS-S by IdS found within a 3 mm dried blood spot specifically produces a nonsulfated pro

169 onstrates the correlation between plasma and dried blood spot specimen citrulline concentrations afte

170 Serum and dried blood spot specimens collected for yaws surveillan

171 protocol to assess resistance using remnant dried blood spot specimens from a representative sample

172 teen FFPET (heart) and blood (whole blood or dried blood spot) specimens underwent targeted next-gene

173 Diet and dried blood spot TC and omega-3 (n-3) index were determi

174 Blood specimens were collected using the dried blood spot technique from 9629 residents (87.6%),

175 e sample volume restrictions associated with dried-blood-spot technology.

176 Median age at first dried blood spot test was 2.1 (IQR 1.8-2.5) months.

177 808 (67%) individuals with a first negative dried blood spot test, 14 223 (80%) had subsequent dried

178 n untreated infants in Malawi by analysis of dried blood spots tested by nucleic acid silica-bound am

179 ect on adherence, assessed by drug levels in dried blood spots tested monthly for the first 3 months.

180 Early infant diagnosis with dried blood spot testing had high uptake in primary care

181 Early infant diagnosis with dried blood spot testing was provided by the National AI

182 blood spot test, 14 223 (80%) had subsequent dried blood spot tests, of whom 503 seroconverted after

183 procedure to extract DNA from a portion of a dried blood spot that provides sufficient unamplified ge

184 y blood-smear microscopy and PCR analysis of dried blood spots that had been collected every 2 weeks

185 Dried blood spots that had been stored ambiently for 3 t

186 port, we introduce a 2-tier system using the dried blood spot to first assess CK with follow-up DMD g

187 ting, and uses predetermined levels of CK on dried blood spots to predict DMD gene mutations.

188 The use of dried blood spots to stabilise and ship samples from cli

189 This article compares cotinine levels in dried blood spots to those in umbilical cord blood to as

190 matory markers were measured in eluates from dried blood spots using a bead-based multiplex assay.

191 HIV-1 RNA viral load measurements taken from dried blood spots using a reference panel and field-coll

192 ive PCR assay with DNA isolated from routine dried blood spots was developed.

193 Glucocerebrosidase enzymatic activity in dried blood spots was measured by a mass spectrometry-ba

194 Cotinine in dried blood spots was measured in 6.35--mm punches by us

195 The most sensitive parameter in dried blood spots was the ratio of receptor/ferritin, wh

196 ween February, 2014, and March, 2015, 99,243 dried blood spots were analysed and results were availab

197 Dried blood spots were extracted using a methanolic solu

198 Repeated measures of cotinine in dried blood spots were highly correlated (R(2) = 0.99, P

199 regression revealed that cotinine levels in dried blood spots were slightly lower than those in umbi

200 Tenofovir diphosphate concentrations in dried blood spots were stable and high.

201 orrelated (R(2) = 0.99, P < 0.001) among 100 dried blood spots with cotinine quantitated in 2 separat